GI-6000

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGI-6000

Drug Alias Namebreast cancer therapy (GlobeImmune)mucin 1 antigen-based therapy (GlobeImmune)mucin-1 immunotherapy (GlobeImmune)breast cancer therapy (GlobeImmune)MUC-1 immunotherapy (GlobeImmune) +[6]

ClassificationVaccines

Mechanisms of ActionMucin-1 stimulants

TargetsMucin-1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlobeimmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlobeimmune Inc

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A